| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,390,000 |
| Market
Cap: |
640.83(M) |
| Last
Volume: |
440,023 |
Avg
Vol: |
603,925 |
| 52
Week Range: |
$12.01 - $41.37 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Wholesale |
| Level
III Sector: |
Drugs Wholesale |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Nu Skin Enterprises develops and distributes a line of beauty and wellness solutions. Co. develops and distributes products in its primary product categories, personal care products and wellness products, under its Nu Skin and Pharmanex brands, respectively. Co.'s personal care products include its skin care devices. Co.'s skin care devices and related consumables include ageLOC Spa systems and its ageLOC LumiSpa skin treatment and cleansing device. Co.'s wellness products include its LifePak nutritional supplements, ageLOC Youth nutritional supplements and ageLOC TR90 weight management and body shaping system.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,000 |
27,400 |
47,995 |
441,153 |
| Total Sell Value |
$74,240 |
$456,612 |
$1,005,702 |
$17,634,733 |
| Total People Sold |
1 |
1 |
4 |
10 |
| Total Sell Transactions |
3 |
7 |
16 |
51 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Napierski Ryan S |
President and CEO |
• • – |
2022-05-25 |
4 |
OE |
$30.63 |
$856,100 |
D/D |
25,000 |
147,683 |
|
- |
|
| Lipman Andrew D |
Director |
– • – |
2022-05-23 |
4 |
AS |
$44.95 |
$44,950 |
D/D |
(1,000) |
70,214 |
|
- |
|
| Lund Steven |
Exec. Chairman of the Board |
• • – |
2022-05-18 |
4 |
S |
$46.07 |
$42,615 |
I/I |
(925) |
179,449 |
|
- |
|
| Lund Steven |
Exec. Chairman of the Board |
• • – |
2022-05-16 |
4 |
S |
$45.25 |
$959,300 |
I/I |
(21,200) |
180,374 |
|
- |
|
| Lund Steven |
Exec. Chairman of the Board |
• • – |
2022-05-13 |
4/A |
GD |
$0.00 |
$0 |
I/I |
14,010 |
202,499 |
|
- |
|
| Lund Steven |
Exec. Chairman of the Board |
• • – |
2022-05-13 |
4 |
GD |
$0.00 |
$0 |
I/I |
14,935 |
201,574 |
|
- |
|
| Lipman Andrew D |
Director |
– • – |
2022-04-22 |
4 |
AS |
$47.72 |
$47,720 |
D/D |
(1,000) |
71,214 |
|
- |
|
| Tang Connie Mang Yee |
Chief Global Growth Officer |
• – – |
2022-04-21 |
4 |
D |
$47.50 |
$53,200 |
D/D |
(1,120) |
31,687 |
|
- |
|
| Tang Connie Mang Yee |
Chief Global Growth Officer |
• – – |
2022-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,264 |
32,807 |
|
- |
|
| Lipman Andrew D |
Director |
– • – |
2022-03-22 |
4 |
AS |
$47.40 |
$47,400 |
D/D |
(1,000) |
72,214 |
|
- |
|
| Woodbury Edwina D |
Director |
– • – |
2022-03-09 |
4 |
A |
$47.90 |
$575 |
D/D |
12 |
13,488 |
|
- |
|
| Chang Joseph Y |
Chief Scientific Officer |
• – – |
2022-03-02 |
4 |
AS |
$45.86 |
$157,597 |
D/D |
(3,423) |
22,957 |
|
- |
|
| Chang Joseph Y |
Chief Scientific Officer |
• – – |
2022-03-02 |
4 |
OE |
$30.63 |
$104,846 |
D/D |
3,423 |
26,380 |
|
- |
|
| Chang Joseph Y |
Chief Scientific Officer |
• – – |
2022-03-01 |
4 |
AS |
$45.21 |
$1,292,213 |
D/D |
(28,577) |
22,957 |
|
- |
|
| Chang Joseph Y |
Chief Scientific Officer |
• – – |
2022-03-01 |
4 |
OE |
$30.63 |
$875,314 |
D/D |
28,577 |
51,534 |
|
- |
|
| Chang Joseph Y |
Chief Scientific Officer |
• – – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,744 |
22,957 |
|
- |
|
| Clark Chayce David |
EVP and General Counsel |
• – – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,430 |
23,541 |
|
- |
|
| Hatchett Steven Keith |
Chief Product Officer |
• – – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,901 |
55,395 |
|
- |
|
| Tang Connie Mang Yee |
Chief Global Growth Officer |
• – – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
9,147 |
27,543 |
|
- |
|
| Thomas James D |
Chief Accounting Officer |
• – – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,557 |
14,324 |
|
- |
|
| Lawrence Mark H |
Chief Financial Officer |
• – – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
11,381 |
54,086 |
|
- |
|
| Napierski Ryan S |
President and CEO |
• • – |
2022-02-25 |
4 |
AS |
$47.28 |
$1,185,046 |
D/D |
(25,000) |
122,683 |
|
- |
|
| Napierski Ryan S |
President and CEO |
• • – |
2022-02-25 |
4 |
OE |
$30.63 |
$896,410 |
D/D |
25,000 |
147,683 |
|
- |
|
| Napierski Ryan S |
President and CEO |
• • – |
2022-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
31,613 |
122,683 |
|
- |
|
| Lipman Andrew D |
Director |
– • – |
2022-02-22 |
4 |
AS |
$53.27 |
$53,270 |
D/D |
(1,000) |
73,214 |
|
- |
|
1358 Records found
|
|
Page 6 of 55 |
|
|
0.28 (2.2%) 
